Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2

Translated title of the contribution: Pioglitazone, an effective alternative still valid for the control of type 2 diabetes

Manuel González-Ortiz, María Guadalupe Castro-Martínez, Carolina Solís-Herrera, Elvira Graciela Alexanderson-Rosas, Eduardo Márquez-Rodríguez, Ángel Alfonso Garduño-Pérez, Alfredo Israel Servin-Caamaño, Manuel Duarte-Vega, Esperanza Martínez-Abundis, Enrique Cuitláhuac Morales-Villegas, Rafael Margarito Violante-Ortiz

Research output: Contribution to journalArticlepeer-review

Abstract

This manuscript consists of a compacted review of pioglitazone, a thiazolidinedione which over the years has showed multiple beneficial effects in the treatment of type 2 diabetes that go beyond glycemic control and whose description intends to give to this glitazone the fair value that it has at the present time within the therapeutic arsenal and international recommendations for the management of patients with this disease.

Translated title of the contributionPioglitazone, an effective alternative still valid for the control of type 2 diabetes
Original languageSpanish
Pages (from-to)800-812
Number of pages13
JournalMedicina Interna de Mexico
Volume37
Issue number5
DOIs
StatePublished - Sep 2021

Keywords

  • Glitazone
  • Pioglitazone
  • Thiazolidinedione
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Pioglitazone, an effective alternative still valid for the control of type 2 diabetes'. Together they form a unique fingerprint.

Cite this